Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | HLA-DMA |
Upstream (Parents) |
---|
(<<) CD74 → HLA-DMA |
(<<) HLA-DMB → HLA-DMA |
(<<) CD86 → HLA-DMA |
Downstream (Children) |
---|
HLA-DMA → PSMB9 (>>) |
HLA-DMA → CRTAM (>>) |
HLA-DMA → GFI1 (>>) |
HLA-DMA → CAB39L (>>) |
HLA-DMA → GM2A (>>) |
HLA-DMA → SIGLEC9 (>>) |
HLA-DMA → SLAMF7 (>>) |
HLA-DMA → APOBEC3G (>>) |
HLA-DMA → CFD (>>) |
HLA-DMA → HLA-DMB (>>) |
HLA-DMA → UCP2 (>>) |